Anisotropic engineered heart tissue made from laser-cut decellularized myocardium

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Schwan, Jonas ^a   Kwaczala, Andrea T ^a,b   Ryan, Thomas J ^a   Bartulos, Oscar ^c   Ren, Yongming ^c   Sewanan, Lorenzo R ^a   Morris, Aaron H ^a,c   Jacoby, Daniel L ^c   Qyang, Yibing ^c   Campbell, Stuart G ^a,c  

^a Yale University   (United States)

^b UNIVERSITY OF HARTFORD   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; POLITEF;

ANIMAL; ANISOTROPY; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL CULTURE TECHNIQUE; CYTOLOGY; DEVICES; DRUG EFFECT; EMBRYONIC STEM CELL; GAS LASER; HEART CONTRACTION; INDUCED PLURIPOTENT STEM CELL; MECHANOTRANSDUCTION; OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGY; PIG; PROCEDURES; RAT; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ANIMALS; ANISOTROPY; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; LASERS, GAS; MECHANOTRANSDUCTION, CELLULAR; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; POLYTETRAFLUOROETHYLENE; RATS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TRIIODOTHYRONINE;

EID: 84985896359     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32068     Document Type: Article

References (59)

1. Morita, H., Nagai, R., Seidman, J. G. & Seidman, C. E. Sarcomere gene mutations in hypertrophy and heart failure. J. of Cardiovasc. Trans. Res. 3, 297-303 (2010).
2. McCain, M. L. & Parker, K. K. Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function. Pflugers Arch - Eur J Physiol 462, 89-104 (2011).
3. Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214-224 (2016).
4. Hirt, M. N., Hansen, A. & Eschenhagen, T. Cardiac Tissue Engineering: State of the Art. Circ Res 114, 354-367 (2014).
5. Schwan, J. & Campbell, S. G. Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes. Biomark Insights 10, 91-103 (2015).
6. Eschenhagen, T., Eder, A., Vollert, I. & Hansen, A. Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol 303, H133-H143 (2012).
7. Ma, S. P. & Vunjak-Novakovic, G. Tissue-Engineering for the Study of Cardiac Biomechanics. J Biomech Eng 138, 021010 (2016).
8. Ross, R. S. & Borg, T. K. Integrins and the myocardium. Circ Res 88, 1112-1119 (2001).
9. Hoshijima, M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 290, H1313-25 (2006).
10. Lin, D. H. & Yin, F. C. A multiaxial constitutive law for mammalian left ventricular myocardium in steady-state barium contracture or tetanus. J Biomech Eng 120, 504-517 (1998).
11. Guyette, J. P. et al. Bioengineering Human Myocardium on Native Extracellular Matrix. Circ Res 118, 56-72 (2015).
12. Ott, H. C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213-221 (2008).
13. Lu, T.-Y. et al. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nature Communications 4, 1-11 (2013).
14. Blazeski, A., Kostecki, G. M. & Tung, L. Engineered heart slices for electrophysiological and contractile studies. Biomaterials 55, 119-128 (2015).
15. Kang, T., Humphrey, J. D. & Yin, F. C. Comparison of biaxial mechanical properties of excised endocardium and epicardium. Am. J. Physiol. 270, H2169-76 (1996).
16. Oberwallner, B. et al. Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium. J Biomed Mater Res A 102, 3263-3272 (2014).
17. Bartulos, O. et al. ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction. JCI Insight 1, 1-17 (2016).
18. Wang, Y. et al. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Circ Res 111, 1494-1503 (2012).
19. Seki, T., Yuasa, S. & Fukuda, K. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nature Protocols 7, 718-728 (2012).
20. Yeung, E. W. et al. Effects of stretch-activated channel blockers on [Ca 2+ ] iand muscle damage in the mdxmouse. The Journal of Physiology 562, 367-380 (2005).
21. Simpson, P. & Savion, S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res 50, 101-116 (1982).
22. Birket, M. J. et al. Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSCCardiomyocyte Function. Cell Rep 13, 733-745 (2015).
23. Gustafson, T. A., Markham, B. E., Bahl, J. J. & Morkin, E. Thyroid hormone regulates expression of a transfected alpha-myosin heavy-chain fusion gene in fetal heart cells. Proc Natl Acad Sci USA 84, 3122-3126 (1987).
24. LeGrice, I. J., Takayama, Y. & Covell, J. W. Transverse shear along myocardial cleavage planes provides a mechanism for normal systolic wall thickening. Circ Res 77, 182-193 (1995).
25. Feigl, E. O. & Fry, D. L. Intramural Myocardial Shear during the Cardiac Cycle. Circ Res 14, 536-540 (1964).
26. Frank, D. et al. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51, 309-318 (2008).
27. Nishikimi, T., Maeda, N. & Matsuoka, H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69, 318-328 (2006).
28. Dong, S. J. et al. Independent effects of preload, afterload, and contractility on left ventricular torsion. Am. J. Physiol. 277, H1053-60 (1999).
29. Gaborit, F. et al. Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure. BMC Cardiovasc Disord 15, 92 (2015).
30. Law, C., Glover, C., Benson, K. & Guglin, M. Extremely high brain natriuretic peptide does not reflect the severity of heart failure. Congest Heart Fail 16, 221-225 (2010).
31. Simon, D. D., Horgan, C. O. & Humphrey, J. D. Mechanical restrictions on biological responses by adherent cells within collagen gels. Journal of the Mechanical Behavior of Biomedical Materials 14, 216-226 (2012).
32. Costa, K. D., Lee, E. J. & Holmes, J. W. Creating alignment and anisotropy in engineered heart tissue: role of boundary conditions in a model three-dimensional culture system. Tissue Eng. 9, 567-577 (2003).
33. Lee, E. J., Holmes, J. W. & Costa, K. D. Remodeling of Engineered Tissue Anisotropy in Response to Altered Loading Conditions. Annals of Biomedical Engineering 36, 1322-1334 (2008).
34. Black, L. D., Meyers, J. D., Weinbaum, J. S., Shvelidze, Y. A. & Tranquillo, R. T. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Engineering Part A 15, 3099-3108 (2009).
35. Bian, W., Liau, B., Badie, N. & Bursac, N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nature Protocols 4, 1522-1534 (2009).
36. Hirt, M. N. et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 107, 307-16 (2012).
37. Tulloch, N. L. et al. Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture. Circ Res 109, 47-59 (2011).
38. Cashman, T. J., Josowitz, R., Johnson, B. V., Gelb, B. D. & Costa, K. D. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy. PLoS ONE 11, e0146697 (2016).
39. Grosberg, A., Alford, P. W., McCain, M. L. & Parker, K. K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 11, 4165-4173 (2011).
40. Boudou, T. et al. A Microfabricated Platform to Measure and Manipulate the Mechanics of Engineered Cardiac Microtissues. Tissue Engineering Part A 18, 910-919 (2012).
41. Huebsch, N. et al. Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses. Sci Rep 6, 24726 (2016).
42. Radisic, M. et al. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93, 332-343 (2006).
43. Zimmermann, W. H. et al. Tissue Engineering of a Differentiated Cardiac Muscle Construct.Circ Res 90, 223-230 (2001).
44. Turnbull, I. C. et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. The FASEB Journal 28, 644-654 (2014).
45. Feinberg, A. W. et al. Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture. Biomaterials 33, 5732-5741 (2012).
46. Pong, T. et al. Hierarchical architecture influences calcium dynamics in engineered cardiac muscle. Experimental Biology and Medicine 236, 366-373 (2011).
47. Bian, W., Jackman, C. P. & Bursac, N. Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication 6, 024109-11 (2014).
48. Moreno-Gonzalez, A. et al. Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol 47, 603-613 (2009).
49. Raman, S., Kelley, M. A. & Janssen, P. M. L. Effect of muscle dimensions on trabecular contractile performance under physiological conditions. Pflugers Arch - Eur J Physiol 451, 625-630 (2006).
50. Eschenhagen, T., Eder, A., Vollert, I. & Hansen, A. Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol 303, H133-H143 (2012).
51. Hirt, M. N. et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 74, 151-161 (2014).
52. Turnbull, I. C. et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. The FASEB Journal 28, 644-654 (2014).
53. Morgan, K. Y. & Black, L. D. Investigation into the effects of varying frequency of mechanical stimulation in a cycle-by-cycle manner on engineered cardiac construct function. J Tissue Eng Regen Med n/a-n/a doi: 10.1002/term.1915 (2014).
54. Yang, X. et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 72, 296-304 (2014).
55. Hinson, J. T. et al. HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Sci 349, 982-986 (2015).
56. Ford, S. J., Mamidi, R., Jimenez, J., Tardiff, J. C. & Chandra, M. Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform. J Mol Cell Cardiol 53, 542-551 (2012).
57. Milani-Nejad, N. & Janssen, P. M. L. Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol. Ther. 141, 235-249 (2014).
58. Mulieri, L. A., Hasenfuss, G., Leavitt, B., Allen, P. D. & Alpert, N. R. Altered myocardial force-frequency relation in human heart failure. Circulation 85, 1743-1750 (1992).
59. Godier-Furnémont, A. F. G. et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials 60, 82-91 (2015).